Stockscreener 앱 받기
1.855
7.04%
-0.135
전일 마감가:
$1.99
열려 있는:
$2
하루 거래량:
383.86K
Relative Volume:
0.55
시가총액:
$131.21M
수익:
$299.48M
순이익/손실:
$-86.45M
주가수익비율:
-1.2367
EPS:
-1.5
순현금흐름:
$-17.32M
1주 성능:
-11.48%
1개월 성능:
-24.80%
6개월 성능:
-38.33%
1년 성능:
-65.99%
1일 변동 폭
$1.84
$2.005
1주일 범위
$1.84
$2.18
52주 변동 폭
$1.84
$5.6825
Health Catalyst Inc Stock (HCAT) Company Profile
명칭
Health Catalyst Inc
전화
801-708-6800
주소
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, TEM, BTSG, HQY, DOCS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.855 | 140.75M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
170.66 | 29.10B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
49.80 | 9.54B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
38.45 | 7.22B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
74.63 | 6.57B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
24.59 | 4.80B | 550.17M | 201.35M | 232.07M | 1.00 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-27 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-08-08 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-01-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2024-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-13 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-11-13 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-05-10 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-05-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | 개시 | Stephens | Equal-Weight |
| 2023-04-04 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-10-31 | 개시 | Wells Fargo | Equal Weight |
| 2022-10-25 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-05 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-03-17 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-10-14 | 개시 | BTIG Research | Buy |
| 2021-04-29 | 재개 | JP Morgan | Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-07-14 | 개시 | Citigroup | Buy |
| 2020-06-18 | 개시 | Stifel | Buy |
| 2020-06-15 | 재개 | Evercore ISI | Outperform |
| 2020-05-15 | 개시 | Guggenheim | Buy |
| 2020-04-21 | 개시 | RBC Capital Mkts | Outperform |
| 2020-04-13 | 개시 | SVB Leerink | Outperform |
| 2020-04-02 | 개시 | Canaccord Genuity | Buy |
| 2019-12-20 | 개시 | Raymond James | Strong Buy |
| 2019-10-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-08-19 | 개시 | Evercore ISI | Outperform |
| 2019-08-19 | 개시 | Goldman | Buy |
| 2019-08-19 | 개시 | JP Morgan | Overweight |
| 2019-08-19 | 개시 | Piper Jaffray | Overweight |
| 2019-08-19 | 개시 | SVB Leerink | Outperform |
| 2019-08-19 | 개시 | SunTrust | Buy |
| 2019-08-19 | 개시 | William Blair | Outperform |
모두보기
Health Catalyst Inc 주식(HCAT)의 최신 뉴스
Will Health Catalyst Inc. stock maintain growth storyJuly 2025 Intraday Action & Stepwise Swing Trade Plans - mfd.ru
Health Catalyst leverages AI to enhance clinical outcomes - Traders Union
What drives Health Catalyst Incs stock priceTrade Performance Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
3 of Wall Street's Favorite Stocks We Approach with Caution - Finviz
Marquis Who's Who Honors Kristin Acree for Expertise in Public Health - lelezard.com
Why Health Catalyst (HCAT) Stock Is Trading Lower Today - Finviz
How Health Catalyst Turns Analytics Into Action Clinicians Actually Use - Healthcare IT Today
Bear Alert: What is the cash position of GOGOQuarterly Portfolio Review & Risk Managed Trade Strategies - baoquankhu1.vn
Health Catalyst, Inc (HCAT) Stock Analysis: Exploring a Compelling 76.94% Upside Potential - DirectorsTalk Interviews
Here's Why Health Catalyst (HCAT) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Analyst Calls: What is the dividend yield of Snowflake IncJuly 2025 Momentum & Long-Term Growth Portfolio Plans - baoquankhu1.vn
How The New Price Target Is Reframing Health Catalyst’s Story And Fair Value - Yahoo Finance
Support Test: Should I set a stop loss on Health Catalyst IncJuly 2025 Market Mood & Daily Growth Stock Tips - baoquankhu1.vn
Navigating 2026: How health systems can thrive amid AI, labor and consumer pressures - Modern Healthcare
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Health Catalyst Announces Chief Commercial Officer Transition Plan - TipRanks
Health Catalyst, Inc. Announces Executive Changes - marketscreener.com
Health Catalyst, MongoDB, Asana, Domo, and RingCentral Stocks Trade Up, What You Need To Know - The Globe and Mail
Health Catalyst, Inc (HCAT) Stock Analysis: Evaluating the 68% Potential Upside for Investors - DirectorsTalk Interviews
Why Clinical Data Analytics Is Becoming One of Healthcare’s Fastest-Growing Markets? - GlobeNewswire Inc.
Q3 Earnings Highs And Lows: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics Stocks - Barchart.com
Nasdaq Moves: What are Health Catalyst Incs recent SEC filings showingMarket Movers & Daily Chart Pattern Signals - baoquankhu1.vn
Health Catalyst, Veeva Systems, 8x8, Amplitude, and DocuSign Stocks Trade Down, What You Need To Know - The Globe and Mail
Market Outlook: Can Health Catalyst Inc stock weather global recessionStop Loss & Risk Managed Investment Strategies - Bộ Nội Vụ
Health Catalyst stock reiterated as Buy at Stifel despite 2026 revenue guide - Investing.com Australia
Health Catalyst stock reiterated as Buy at Stifel despite 2026 revenue guide By Investing.com - Investing.com South Africa
HCAT Projects Strong Client Growth and EBITDA Goals for FY25 - GuruFocus
(HCAT) Health Catalyst Expects 2025 Revenue to Slightly Exceed Guidance of About $310 Million - marketscreener.com
Health Catalyst drives AI in healthcare to cut costs - Traders Union
Surprises Report: Is Health Catalyst Inc stock a top pick in earnings seasonJuly 2025 Outlook & Verified Swing Trading Watchlists - moha.gov.vn
Health Catalyst examines AI's tangible impact on healthcare - Traders Union
4 Analysts Have This To Say About Health Catalyst - Benzinga
HCAT: Citigroup Adjusts Price Target, Maintains Neutral Rating | - GuruFocus
Is Health Catalyst Inc. stock positioned well for digital economyWalking Comfort Picks & what to check before ordering - Улправда
Is Health Catalyst Inc. stock a top pick in earnings seasonJuly 2025 PreEarnings & Low Risk High Win Rate Picks - Улправда
How Health Catalyst Inc. stock compares to growth peers2025 Fundamental Recap & AI Powered Market Entry Strategies - Улправда
Can Health Catalyst Inc. stock rebound after recent weaknessMarket Rally & AI Driven Stock Movement Reports - Улправда
Is Health Catalyst Inc. stock a dividend growth opportunityJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - Улправда
Is Health Catalyst Inc. stock oversold or undervaluedMarket Risk Summary & Technical Pattern Alert System - Улправда
EPS Watch: Is Health Catalyst Inc stock positioned well for digital economy2025 Market Sentiment & Free Expert Approved Momentum Trade Ideas - Bộ Nội Vụ
3 Russell 2000 Stocks Walking a Fine Line - Finviz
3 Value Stocks We Find Risky - Finviz
Health Catalyst Inc (HCAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Health Catalyst Inc 주식 (HCAT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Larson-Green Julie | Director |
Dec 04 '25 |
Sale |
2.67 |
47,997 |
128,349 |
73,573 |
8.13%
1.70%
자본화:
|
볼륨(24시간):